4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000950170-25-094572
Interim CFO sold 147 shares at $3.39 ($498)
- Interim CFO acquired 374 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Firmani Lori Interim CFO | 2025-07-03 | Option exercise | +374 | 839 | D | ||
| Firmani Lori Interim CFO | 2025-07-03 | Sale | −147 | $3.39 | $498 | 692 | D |
| Derivatives | |||||||
| Firmani Lori Interim CFO | 2025-07-03 | Option exercise · Restricted Stock Units | −374 | 1,100 | D | ||
| Open-market sales · 147 sh · avg $3.39 · $498 | |||||||
Loading xslF345X05/ownership.xml…